article thumbnail

The Power of Lipids: Enhancing Drug Delivery with Nanoparticles

Roots Analysis

SLNs offer various benefits, such as easy production process, good release profile and low cost. However, their drawbacks include limited drug loading capacity and potential drug expulsion during storage. The LNPs can be monitored using various imaging modalities to confirm the delivery of siRNA to the target cells.

article thumbnail

Covid-19 vaccine success bolsters nanoparticle drug delivery research

Pharmaceutical Technology

Due to their size, cells can absorb them where they release products. Using nanomedicine to overcome drug delivery barriers Apart from lipid nanoparticles, nanoparticle-related innovation is also reaching other types of drug development. Lipid nanoparticles are spherical vehicles made from ionizable lipids.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biopharmaceutical Excipient Manufacturing – Current Scenario and Future Trends

Roots Analysis

In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines and gene therapies), by the US FDA, have steadily risen. In fact, over 8,000 biological pharmaceutical products are currently under clinical investigation worldwide. Web: [link].

article thumbnail

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

XTalks

According to an analysis of the 2013 Medical Expenditure Panel Survey, one in six US adults reported taking a psychiatric drug at least once in 2013. Global sales of over-the-counter and prescription products related to central nervous system (CNS) disease added up to $86 billion in 2019. Next Steps for Targeted CNS Delivery.

Trials 83